<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-83901</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Early development of leaks in the CoreValve percutaneous aortic valve prosthesis: echocardiographic assessment</dc:title>
<dc:description xml:lang="en">The study investigated echocardiographic findings after 1 month in 22 patients who received a CoreValve prostheses to treat aortic valve stenosis. Particular attention was paid to the evaluation of valvular leaks and the left ventricular wall thickness. Echocardiograms were obtained prior to implantation, at discharge and 1 month later. The patients&#146; mean age was 77 +/- 4 years. At discharge, 16 patients (76%) had aortic regurgitation: 8 grade I and 8 grade II. At 1 month, only 13 (62%) presented with the condition: 10 grade I and 3 grade II, with 8 patients (38%) demonstrating a reduction of at least one grade (P &lt; .005). The septal thickness decreased (from 14.2   2 mm at baseline to 11 +/- 2.4 mm at 1 month; P &lt; .001), as did the posterior wall thickness (from 10.9 +/- 2.4 mm at baseline to 8.3 +/- 1.2 mm at 1 month; P &lt; .001). In our patient series, the frequency and grade of residual aortic regurgitation after implantation of the CoreValve prosthesis decreased within 1 month, and favorable left ventricular remodeling was also observed (AU)</dc:description>
<dc:creator>Delgado, Mónica</dc:creator>
<dc:creator>Suárez de Lezo, José</dc:creator>
<dc:creator>Romero, Miguel</dc:creator>
<dc:creator>Mesa, Dolores</dc:creator>
<dc:creator>Segura, José</dc:creator>
<dc:creator>León, Carmen</dc:creator>
<dc:creator>Pan, Manuel</dc:creator>
<dc:creator>Ruiz, MArtín</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se evaluaron los resultados ecocardiográficos al mes en 22 pacientes con estenosis aórtica valvular tratados con prótesis CoreValve, con especial interés en la valoración de fugas valvulares y el grosor de paredes ventriculares izquierdas. Realizamos ecocardiograma previo al implante, al alta y al mes. La media de edad fue de 77±4 años. Al alta 16 pacientes (76%) tenían regurgitación aórtica: 8 de grado I y 8 de grado II. Al mes sólo 13 (62%) la presentaban: 10 en grado I y 3 en grado II, y se redujo al menos un grado en 8 pacientes (38%) (p&lt;0,005). Se redujo el grosor septal (14,2±2 mm basal frente a 11±2,4 mm al mes; p&lt;0,001) y de pared posterior (10,9±2,4 mm basal frente a 8,3±1,2 mm al mes; p&lt;0,001). En nuestra serie, la frecuencia y el grado de regurgitación aórtica residual tras el implante de la prótesis CoreValve disminuyeron al mes, y además se observó un remodelado ventricular favorable (AU)</dc:description>
<dc:source>Rev Esp Cardiol;64(1): 67-70, ene. 2011. tab, ilus</dc:source>
<dc:identifier>ibc-83901</dc:identifier>
<dc:title xml:lang="es">Evolución precoz de fugas en prótesis aórtica percutánea CoreValve: valoración ecocardiográfica</dc:title>
<dc:subject>^d28599</dc:subject>
<dc:subject>^d23233^s22039</dc:subject>
<dc:subject>^d1028^s29166</dc:subject>
<dc:subject>^d23233^s22045</dc:subject>
<dc:subject>^d23233^s22066</dc:subject>
<dc:subject>^d1027^s29166</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d22488^s22066</dc:subject>
<dc:subject>^d1028^s22009</dc:subject>
<dc:subject>^d1027^s22009</dc:subject>
<dc:subject>^d22488^s22020</dc:subject>
<dc:subject>^d22488^s22074</dc:subject>
<dc:subject>^d11916^s22074</dc:subject>
<dc:subject>^d23233^s22074</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:type>article</dc:type>
<dc:date>201101</dc:date>
</metadata>
</record>
</ibecs-document>
